IMPL
NASDAQImpel Pharmaceuticals Inc.
Impel Pharmaceuticals Inc. (IMPL) is a Biotechnology: Pharmaceutical Preparations company listed on NASDAQ. There were no new wire items for IMPL in the last 30 days. The most recent was published Feb 16, 2024.
Latest news
25 items- SECSEC Form EFFECT filed by Impel Pharmaceuticals Inc.EFFECT - IMPEL PHARMACEUTICALS INC (0001445499) (Filer)
- SECSEC Form S-8 POS filed by Impel Pharmaceuticals Inc.S-8 POS - IMPEL PHARMACEUTICALS INC (0001445499) (Filer)
- SECSEC Form S-8 POS filed by Impel Pharmaceuticals Inc.S-8 POS - IMPEL PHARMACEUTICALS INC (0001445499) (Filer)
- SECSEC Form S-8 POS filed by Impel Pharmaceuticals Inc.S-8 POS - IMPEL PHARMACEUTICALS INC (0001445499) (Filer)
- SECSEC Form POS AM filed by Impel Pharmaceuticals Inc.POS AM - IMPEL PHARMACEUTICALS INC (0001445499) (Filer)
- SECImpel Pharmaceuticals Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Entry into a Material Definitive Agreement, Bankruptcy or Receivership8-K - IMPEL PHARMACEUTICALS INC (0001445499) (Filer)
- SECImpel Pharmaceuticals Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - IMPEL PHARMACEUTICALS INC (0001445499) (Filer)
- SECSEC Form 25-NSE filed by Impel Pharmaceuticals Inc.25-NSE - IMPEL PHARMACEUTICALS INC (0001445499) (Subject)
- INSIDERSEC Form 3 filed by new insider Smith Brandon D3 - IMPEL PHARMACEUTICALS INC (0001445499) (Issuer)
- SECImpel Pharmaceuticals Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Bankruptcy or Receivership, Events That Accelerate or Increase a Direct Financial Obligation, Leadership Update, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits8-K - IMPEL PHARMACEUTICALS INC (0001445499) (Filer)
- PRImpel Pharmaceuticals Announces Filing of Voluntary Chapter 11 Cases and Signing of "Stalking Horse" Agreement to Facilitate SalePatient Access to Trudhesa® to Continue Uninterrupted Sufficient Liquidity to Fund Day to Day Operations During Court-Supervised Process SEATTLE, Dec. 19, 2023 /PRNewswire/ -- Impel Pharmaceuticals Inc. (OTCQX:IMPL) ("Impel" or "the Company"), a commercial-stage biopharmaceutical company with a mission to develop transformative therapies for people suffering from diseases with high unmet medical needs, today announced that it is pursuing a sale of the Company and has entered into an agreement with JN BIDCO LLC to serve as the "stalking horse" bidder to acquire the Company and its assets.
- INSIDERVivo Capital Viii, Llc sold $74,131 worth of shares (575,000 units at $0.13) (SEC Form 4)4 - IMPEL PHARMACEUTICALS INC (0001445499) (Issuer)
- SECImpel Pharmaceuticals Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing8-K - IMPEL PHARMACEUTICALS INC (0001445499) (Filer)
- NEWS12 Health Care Stocks Moving In Friday's After-Market SessionGainers Alaunos Therapeutics (NASDAQ:TCRT) stock rose 20.9% to $0.06 during Friday's after-market session. The company's market cap stands at $13.2 million. Impel Pharmaceuticals (NASDAQ:IMPL) shares rose 11.98% to $0.27. The company's market cap stands at $6.4 million. I-MAB (NASDAQ:IMAB) shares increased by 7.19% to $1.49. The company's market cap stands at $123.1 million. Genprex (NASDAQ:GNPX) stock rose 6.63% to $0.23. The company's market cap stands at $13.3 million. Ikena Oncology (NASDAQ:IKNA) shares rose 6.59% to $2.1. The company's market cap stands at $101.3 million. Adaptimmune Therapeutics (NASDAQ:ADAP) stock increased by 6.22% to $0.48. The market value of their outstandin
- NEWS12 Health Care Stocks Moving In Tuesday's After-Market SessionGainers Phio Pharma (NASDAQ:PHIO) shares moved upwards by 19.6% to $1.34 during Tuesday's after-market session. The market value of their outstanding shares is at $3.2 million. Lucy Scientific Discovery (NASDAQ:LSDI) shares moved upwards by 9.34% to $0.33. The market value of their outstanding shares is at $5.8 million. Aclaris Therapeutics (NASDAQ:ACRS) stock moved upwards by 8.47% to $1.07. The company's market cap stands at $75.7 million. Minerva Surgical (NASDAQ:UTRS) stock moved upwards by 8.36% to $2.85. The market value of their outstanding shares is at $25.3 million. Pasithea Therapeutics (NASDAQ:KTTA) stock rose 6.77% to $0.32. The market value of their outstanding shares is at
- INSIDERSEC Form 4 filed by Brookfield Corp /On/4 - IMPEL PHARMACEUTICALS INC (0001445499) (Issuer)
- INSIDERSEC Form 4 filed by Oaktree Gcp Fund Delaware Holdings, L.P.4 - IMPEL PHARMACEUTICALS INC (0001445499) (Issuer)
- 13D/GSEC Form SC 13D/A filed by Impel Pharmaceuticals Inc. (Amendment)SC 13D/A - IMPEL PHARMACEUTICALS INC (0001445499) (Subject)
- NEWSOn December 1, 2023, Michael Kalb Gave Notice Of His Resignation From His Position As Chief Financial Officer Of Impel Pharmaceuticals With His Last Day To Be December 31, 2023-8K
- SECImpel Pharmaceuticals Inc. filed SEC Form 8-K: Leadership Update8-K - IMPEL PHARMACEUTICALS INC (0001445499) (Filer)
- NEWSWhy Workday Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving PremarketShares of Workday, Inc. (NASDAQ:WDAY) surged in pre-market trading after the company reported upbeat earnings results for its third quarter. Workday posted earnings of $1.56 per share, beating market estimates of $1.41 per share. Revenue of $1.87 billion topped the analyst consensus estimate of $1.848 billion. Workday anticipated fourth-quarter subscription revenue to be $6.598 billion while adjusted operating margins were estimated to be 23.8%. Piper Sandler maintained Workday with an Overweight and raised the price target from $275 to $300. Workday shares rose 9% to $258.70 in pre-market trading Here are some other stocks moving in pre-market trading. Gainers 180 Life Sciences Co
- NEWSUS Stocks Lower; Dow Falls Over 50 PointsU.S. stocks traded lower this morning, with the Dow Jones index falling over 50 points on Monday. Following the market opening Monday, the Dow traded down 0.18% to 35,328.05 while the NASDAQ fell 0.13% to 14,231.78. The S&P 500 also fell, dropping, 0.25% to 4,548.14. Check This Out: IO Biotech And 2 Other Stocks Under $2 Insiders Are Buying Leading and Lagging Sectors Communication services shares edged higher on Monday. In trading on Monday, energy shares fell by 0.7%. Top Headline Shopify Inc (NYSE:SHOP) merchants accomplished a record-breaking $4.1 billion in sales on Black Friday, marking a 22% increase from the previous year. Sales peaked when collective sales reach
- NEWSWhy UP Fintech Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving PremarketShares of UP Fintech Holding Limited (NASDAQ:TIGR) surged in pre-market trading after the company results for the third quarter. UP Fintech Holding posted adjusted EPADS of 10 cents up from 4 cents in the year-ago period. The company’s quarterly sales came in at $70.10 million versus, $55.41 million a year earlier. UP Fintech shares rose 7% to $5.20 in pre-market trading. Here are some other stocks moving in pre-market trading. Gainers Mobiquity Technologies, Inc. (NASDAQ:MOBQ) shares rose 27.3% to $0.5728 in pre-market trading after gaining around 7% on Friday. Apollomics, Inc. (NASDAQ:APLM) shares rose 26.8% to $1.26 in pre-market trading after surging 14% on Friday. The company’s
- NEWS12 Health Care Stocks Moving In Monday's Pre-Market SessionGainers Redhill Biopharma (NASDAQ:RDHL) shares rose 118.7% to $0.69 during Monday's pre-market session. The market value of their outstanding shares is at $7.6 million. Tharimmune (NASDAQ:THAR) stock moved upwards by 39.13% to $4.0. The market value of their outstanding shares is at $2.8 million. Apollomics (NASDAQ:APLM) stock rose 33.37% to $1.33. The company's market cap stands at $119.0 million. 60 Degrees (NASDAQ:SXTP) shares moved upwards by 23.67% to $0.7. The market value of their outstanding shares is at $4.0 million. Sunshine Biopharma (NASDAQ:SBFM) shares moved upwards by 17.58% to $0.33. The market value of their outstanding shares is at $8.4 million. Olema Pharmaceuticals (
- NEWS12 Health Care Stocks Moving In Friday's After-Market SessionGainers Mira Pharmaceuticals (NASDAQ:MIRA) shares moved upwards by 9.2% to $3.59 during Friday's after-market session. The market value of their outstanding shares is at $53.0 million. TC BioPharm (Holdings) (NASDAQ:TCBP) shares moved upwards by 8.17% to $0.61. The company's market cap stands at $5.7 million. Panbela Therapeutics (NASDAQ:PBLA) shares moved upwards by 8.06% to $0.54. The market value of their outstanding shares is at $2.7 million. Estrella Immunopharma (NASDAQ:ESLA) stock rose 7.8% to $1.52. The market value of their outstanding shares is at $53.5 million. Bio-Path Hldgs (NASDAQ:BPTH) stock increased by 7.56% to $0.52. The market value of their outstanding shares is at $
IMPL FAQ
7 questionsWhat does Impel Pharmaceuticals Inc. do?
Impel NeuroPharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of therapies for patients suffering from central nervous system disease in the United States. Its lead product candidate is TRUDHESA, an upper nasal formulation of dihydroergotamine for the acute treatment of migraine. The company is also developing INP105, an upper nasal formulation of olanzapine for the acute treatment of agitation and aggression in autism spectrum disorder; and INP107, an upper nasal formulation of carbidopa/levodopa for the treatment of OFF episodes in...What is the latest news on IMPL?
Quantisnow has not tracked any new filings, ratings or press releases for IMPL in the last 30 days. The most recent wire item was published on February 16, 2024.Where does IMPL stock trade?
Impel Pharmaceuticals Inc. (IMPL) is listed on NASDAQ.What sector and industry is IMPL in?
Impel Pharmaceuticals Inc. operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.When did Impel Pharmaceuticals Inc. go public?
Impel Pharmaceuticals Inc. (IMPL) completed its IPO in 2021.What companies are similar to IMPL?
Notable peers in the same industry include LLY (Eli Lilly and Company), JNJ (Johnson & Johnson), ABBV (AbbVie Inc.), MRK (Merck & Company Inc.), NVS (Novartis AG). Compare IMPL side-by-side with any of them on Quantisnow.How can I track IMPL on Quantisnow?
Quantisnow aggregates Impel Pharmaceuticals Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow IMPL to receive live email and push alerts on every new disclosure.